Corticosteroid + aminoglycoside + polypeptide antibiotic
Dexamethasone with framycetin sulfate and gramicidin
Brand names: Sofradex
Adult dose
Dose: Ear: 2–3 drops TDS–QDS; Eye: 1–2 drops 4–6× daily
Route: Otic / Ophthalmic
Frequency: TDS–QDS
Clinical pearls
- NICE CKS Otitis externa: topical antibiotic + steroid first-line for acute OE
- ENT UK guidance — short courses (≤7 days) and review
- Avoid extended use (>7–14 days) due to sensitisation/superinfection
Contraindications
- Perforated tympanic membrane (ototoxicity risk — relative)
- Viral, fungal or tuberculous infection
- Aminoglycoside hypersensitivity
- Glaucoma (chronic eye use)
Side effects
- Local irritation
- Hypersensitivity
- Ototoxicity (perforated drum)
- Increased IOP / cataract (chronic eye use)
- Superinfection
Interactions
- Other ototoxic drugs
Monitoring
- Symptom resolution
- Ear examination if no response by 7 days
- IOP if extended ophthalmic use
Reference: BNF; NICE CKS Otitis externa; ENT UK; https://bnf.nice.org.uk/drugs/dexamethasone-with-framycetin-sulfate-and-gramicidin/. Verify against your local formulary and the latest BNF before prescribing.
Related
Curated clinical cross-links plus same-class fallbacks.
Calculators
Pathways
- Adult Upper Airway Obstruction (Stridor) · DAS 2015 unanticipated difficult airway; RCEM
- Epistaxis Management · ENT-UK / NICE
- Acute Otitis Media · NICE NG91 2018
- Tonsillitis and Sore Throat · NICE NG84 2018
- Benign Paroxysmal Positional Vertigo · NICE CG124 / AAO-HNS Guidelines
- Acute Rhinosinusitis · NICE NG79 2017 / EPOS 2020